GenoMed is a spin-off company of IMM created in 2004. The mission of GenoMed is to provide cutting-edge technology transfer services relevant for medical applications. Currently, GenoMed offers over 100 different tests that are used in diagnosis, prognosis and therapeutic follow up. GenoMed acts in 3 main medical areas:
Oncology: Molecular and Cytogenetics tests for Hemato-Oncology, including follow up of bone marrow transplantation. Molecular diagnosis (FISH) for Oligodendrogliomas and urinary tract cancer. Hereditary breast cancer.
Infectious Diseases: Sequencing the HIV genome to detect resistance to anti-viral therapy. Genotyping Hepatitis B and C genomes and detecting resistance to anti-viral therapy.
Genotyping Human Papillomavirus. Infection by Aspergillus in immuno suppressed patients: detection of Galactomannan Antigen.
Genetic Diseases: Alzheimer and Parkinson diseases; Fronto-Temporal Dementia. Wilson Disease, Hemochromatosis, Porphyria. Hyperthropic cardiomyopathy; Familiar Hypercholesterolemia; Brugada and Long QT Syndromes. Bone Dysplasias.
Pharmacogenetics: Genetic testing to reduce bleeding associated with Warfarin intake. Genetic testing for management of antidepressive drug therapy. Additionally, GenoMed provides parental and ancestry DNA testing.
Chief Executive Officer